Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Raymond Cohen Insider Profile
11 Followers
Raymond Cohen, Director at Spectrum Pharmaceuticals, holds 0.00 shares in Axonics Modulation Technologies (Ticker: AXNX), holds 27.76K shares in BioLife Solutions (Ticker: BLFS), holds 53.85K shares in Spectrum Pharmaceuticals (Ticker: SPPI).
Raymond Cohen Spectrum Pharmaceuticals (SPPI)Director
Spectrum Pharmaceuticals (SPPI)
Director
Ranked #86,330 out of 99,335 Corporate Insiders
Profitable Transactions
4 out of 11 Profitable Transactions
Average Return
-20.10%
Average return per transaction
Time Frame
Compare to
Insider Roles
Director
Roles that Raymond Cohen holds in companies
Most Profitable Insider Trade
Stock:
Spectrum Pharmaceuticals
(SPPI)
(SPPI)
Rating:Informative Sell
Date:May 15, 2018 - May 15, 2019
Return:+50.20%
The most profitable trade made by Raymond Cohen
Raymond Cohen's Trading History
Spectrum Pharmaceuticals
Jun 21, 2019
―
Uninformative Buy
―
$55.47K
Axonics Modulation Technologies
Nov 15, 2024
―
Uninformative Sell
20.78M
$0.00
BioLife Solutions
Jul 14, 2021
Director
Uninformative Buy
―
$694.35K
List of latest transactions for each holding click on a transaction to see Raymond Cohen's performance on stock
You May Also Like
Raymond Cohen insider profile FAQ
What is the percentage of profitable transactions made by Raymond Cohen?
The percentage of profitable transactions made by Raymond Cohen is 36%.
What is the average return per transaction made by Raymond Cohen?
The average return per transaction made by Raymond Cohen is -20.10%.
What stocks does Raymond Cohen hold?
Raymond Cohen holds: SPPI, AXNX, BLFS stocks.
What was Raymond Cohen’s latest transaction?
Raymond Cohen latest transaction was an Uninformative Sell of $20.78M.
What was Raymond Cohen's most profitable transaction?
Raymond Cohen’s most profitable transaction was an Informative Sell of SPPI stock on May 15, 2018. The return on the trade was 50.20%.
What is Raymond Cohen's role in Spectrum Pharmaceuticals?
Raymond Cohen's role in Spectrum Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.